Overview
Published on 19‑08‑2026 at 03:58 am by Mark Garro on Investing.com, the article highlights the continued strength of August’s earnings season while noting that major U.S. indexes pulled back, leaving the S&P 500 just 1.3 % below its record close set the previous Thursday.
InvestingPro members received a monthly AI‑generated list of high‑conviction picks for under $8 a month during a summer‑sale promotion. In August, the AI‑driven ProPicks models identified several notable winners: Mativ Holdings (NYSE:MATV) rose 38.26 %, Ramaco Resources (NASDAQGS:METC) 26.5 %, and CommVault (NASDAQGS:CVLT) 21.23 %.
Other highlighted performers included Delek US Energy (NYSE:DK) up 81.21 %, Consensus Cloud Solutions (NASDAQGS:CCSI) up 78.32 %, Everforth (NYSE:EFOR) up 75.28 %, Nucor (NYSE:NUE) up 65.93 %, and Molina Healthcare (NYSE:MOH) up 49.91 % since being flagged. Internationally, AI‑picked stocks such as Lenovo Group (SEHK:992) surged 224.58 %, Nordex SE (XTRA:NDX1) 173.46 %, MediaTek (TWSE:2454) 166.77 %, Dogu Aras Enerji Yatirimlari AS (IBSE:ARASE) 136.97 % and Unicaja (BME:UNI) 135.19 % added to the list.
Haemonetics Corp (NYSE:HAE) – Core Focus
Haemonetics, a med‑tech innovator that supplies automated plasma collection systems, blood‑management software, and vascular‑closure devices, jumped another 15.9 % on the day of the article, bringing its total gain to roughly 92 % since the ProPicks AI first flagged the stock. The share price at the time was about $53.28, representing 56 % of its 52‑week high and reflecting a modest P/E multiple of 14.9× and an ultra‑attractive PEG ratio of 0.34.
The price surge was triggered by a landmark U.S. supply agreement with global plasma leader CSL Plasma. Under the contract, CSL will deploy Haemonetics’ NexSys PCS devices equipped with Persona PLUS technology across its collection centers, establishing a long‑term revenue stream for the company.
Financially, Haemonetics reported Q1 2027 revenue of $339.4 million and an adjusted earnings‑per‑share of $1.14. Revenue beat analyst estimates by 6.2 % and EPS exceeded expectations by 8.9 %. The company posted a 58.8 % gross margin, a 19.4 % operating margin and year‑over‑year EBITDA growth of 23.6 %.
Management subsequently raised its full‑year revenue‑growth outlook to a range of 5 %‑8 %. Wall Street analyst price targets stand at $78, while InvestingPro’s internal fair‑value model values the stock at $76, implying a potential upside of roughly 40 %‑45 %.
AI Model Track Record
Since the AI models were launched in November 2023, the ProPicks strategies have delivered a cumulative return of +198.30 %, outperforming the S&P 500 by +116.67 % over the same period. The models evaluate more than 60,000 global equities each month, processing over 15 years of financial data through more than 150 quantitative models. Up to 20 high‑conviction stocks are selected per strategy, each given equal weighting, and the portfolio is rebalanced monthly to add new opportunities, retain strong performers, and remove stocks that no longer meet the criteria.
Subscription Offer
The article repeatedly invites readers to subscribe to InvestingPro, noting that the summer‑sale pricing offers up to 55 % off the regular subscription fee. Subscribers gain access to the full August AI‑pick list, detailed rationales for each stock, and the ability to view the complete set of AI‑powered selections.
Disclaimer
All subscription prices mentioned are accurate at the time of publication and may vary by region. The piece includes standard promotional language and does not constitute investment advice.
---